Clinical Trials Directory

Trials / Unknown

UnknownNCT01068405

Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo

Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo - Assessment of Structural and Clinical Action of Magnetic Resonance Imaging

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Interest of methotrexate in inflammatory rheumatisms was demonstrated since several years. At present time,there is no effective treatment against digital arthritis. The investigators purpose to measure the efficacy of methotrexate on digital arthritis. In this aim, two groups were compared. The first group receive 10mg/week of methotrexate administered in one shot (every Monday for example)during 12 months. The second group receive 10mg/week of placebo according to the same procedure

Conditions

Interventions

TypeNameDescription
DRUGMethotrexateMethotrexate: 10mg/week administered in one time, the same day each week (every monday for example)during 12 months
DRUGPlaceboPlacebo:10mg/week administered in one time, the same day each week (every monday for example)during 12 months

Timeline

Start date
2010-03-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2010-02-15
Last updated
2011-12-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01068405. Inclusion in this directory is not an endorsement.